Results 141 to 150 of about 21,888 (191)

Association of serum total bilirubin with recurrent cardiovascular events in patients with in-stent restenosis: a stratified analysis by inflammatory status. [PDF]

BMC Cardiovasc Disord
Yu M, Jiang Y, Sun Y, Zhang H, Wang TJ, Tian T, Yuan JS, Qian HY, Yang WX.   +8 more
europepmc   +1 more source

Intravascular Brachytherapy for In-Stent Restenosis in Patients With Chronic Kidney Disease. [PDF]

J Soc Cardiovasc Angiogr Interv
Sella G, Kharsa C, Kritya M, Olek D, Teh BS, Anwaar MF, Elias J, El Hajj E, Raizner AE, Farach A, Kleiman NS, Shah A.   +11 more
europepmc   +1 more source

Unveiling a Hidden Threat: Wellens Syndrome as a Manifestation of Critical In-Stent Restenosis. [PDF]

Cureus
Sousou JM, Merry TJ, Marsalisi C, Karan A, Reddy P.   +4 more
europepmc   +1 more source

Research advances in the etiology of in-stent restenosis of coronary arteries. [PDF]

Front Cardiovasc Med
Bai H, Zhang B, Sun Y, Wang X, Luan B, Zhang X.   +5 more
europepmc   +1 more source

A rare optical coherence tomography finding of a striped, low-attenuation plaque protruding into the lumen in in-stent restenosis. [PDF]

Egypt Heart J
Otaka N, Matsusaka H, Morishige K.
europepmc   +1 more source

Dense Calcification of the Common Femoral Artery Is Protective Against In-Stent Restenosis. [PDF]

J Clin Med
Bamdé CC, Goueffic Y, Davaine JM, Lalande A, Guenancia C, Steinmetz E.   +5 more
europepmc   +1 more source

Paclitaxel-Coated Balloon for Treating In-Stent Restenosis in Racial and Ethnic Minority Patients: A Subanalysis From the AGENT IDE Trial. [PDF]

J Am Heart Assoc
Jamil Y, Kirtane A, Yeh RW, Shlofmitz R, Moses J, Bachinsky W, Dohad S, Rudick S, Stoler R, Jefferson BK, Nicholson W, Altman J, Krishnaswamy A, Alaswad K, Kimmelstiel C, Reitman A, Cavalcante R, Tehrani BN, Batchelor WB.   +18 more
europepmc   +1 more source

Sex-Based Differences in Long-Term Outcomes Following Intravascular Brachytherapy for In-Stent Restenosis. [PDF]

J Soc Cardiovasc Angiogr Interv
Kritya M, Kharsa C, Sella G, Olek D, Teh BS, Anwaar MF, Elias J, El Hajj E, Raizner AE, Farach A, Kleiman NS, Shah AR.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

In-Stent Restenosis

Interventional Cardiology Clinics, 2022
In-stent restenosis (ISR) remains a potential complication after percutaneous coronary intervention, even in the era of drug-eluting stents, and its treatment remains suboptimal. Neoatherosclerosis is an important component of the pathology of ISR and is accelerated in drug-eluting stents compared with bare-metal stents.
Kenji, Kawai, Renu, Virmani, Aloke V, Finn   +2 more
openaire   +2 more sources

Stenting for in-stent restenosis

Catheterization and Cardiovascular Interventions, 2000
Intravascular ultrasound studies have shown that additional stent implantation is the only percutaneous technique that allows for recovery of all the lumen area of the original implantation procedure. Despite this theoretical advantage, information on systematic additional stent implantation is still forthcoming, especially concerning the impact of new
D, Antoniucci, R, Valenti, G, Moschi, M, Trapani, G M, Santoro, L, Bolognese, E, Taddeucci, E, Dovellini   +7 more
openaire   +2 more sources